Search by keywords: Connect with us Stay Informed. Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters. Newsletter Sign Up 1835 News Items found In the Lab Neutrophil Recruitment — What's Damage Got to Do with It? Tuesday, May 15, 2018 Immune cells called neutrophils are the first responders to sites of infection. A new study probes what gets them there. Event Sacred Vessels: "Blessing of Hands" Ritual Helps MSK Nurses Move Forward Thursday, May 10, 2018 MSK nurses reaffirm their commitment to healing in the "Blessing of Hands" ceremony. Q&A MSK Nurse and Hodgkin Lymphoma Survivor Shares Her Story Wednesday, May 9, 2018 Meet Nikki Gioia, who treated for Hodgkin lymphoma at MSK and is now an MSK nurse. Feature An Intrepid Pancreatic Cancer Survivor Continues to Live for Adventure Wednesday, May 2, 2018 Summary This story originally appeared in Bridges, our newsletter for cancer survivors. Bridges offers a forum in which patients and their fa... Feature How Social Workers Help People with Cancer: 8 Questions with Penny Damaskos Wednesday, April 25, 2018 Meet MSK Director of Social Work Penny Damaskos and learn how she and her team help people with cancer. In the Clinic Testing for BRCA: What Is the Best Way to Screen for Cancer Genes? Wednesday, April 25, 2018 The BRCA Founder Outreach study was recently launched to look at how patients undergo genetic screenings for cancer. In Brief A Precision Strike to Treat Prostate Cancer Tuesday, April 24, 2018 An antibody that targets a prostate cell protein shows potential for designing safer, more effective prostate cancer therapies. Event Visible Ink Performance Celebrates Writings of MSK Patients and Survivors Friday, April 20, 2018 Visible Ink, a writing program for MSK patients that pairs them with professional mentors, held its tenth anniversary live performance. Roundup Highlights from MSK at the 2018 American Association for Cancer Research Meeting Monday, April 16, 2018 Read up on the latest developments in several key areas of cancer research, including genomic mapping, disease modeling through CRISPR, CAR T therapy, and cancer stem cells. Finding Immunotherapy Combination Offers a Better Chance at Longer Survival for Patients with Metastatic Kidney Cancer Monday, April 16, 2018 Learn about how the immunotherapies ipilimumab (Yervoy®) and nivolumab (Opdivo®) could provide a new option for patients with metastatic renal cell carcinoma. Pagination Load More Book traversal links for Newsroom Previous Newsroom Next Cancer Vaccine Could Prevent Neuroblastoma From Returning After Antibody Treatment